Filing Details
- Accession Number:
- 0001493152-23-032150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-08 17:46:34
- Reporting Period:
- 2023-09-06
- Accepted Time:
- 2023-09-08 17:46:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1873835 | Immix Biopharma Inc. | IMMX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1631486 | Magda Marquet | C/O Immix Biopharma, Inc. 11400 West Olympic Blvd., Suite 200 Los Angeles CA 90064 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-06 | 9,000 | $2.47 | 20,000 | No | 4 | P | Indirect | Via ALMA Life Sciences, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Via ALMA Life Sciences, LLC |
Billionaire Hedge Funds
